AGE Stock Price, News & Analysis
Company Description
AGE (NYSE: AGE) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.
AGE stock has declined 100.0% over the past year.
This page provides a comprehensive overview of AGE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
AGE (AGE) stock. Over the past 12 months, the stock has lost 100.0%.
Latest News
AGE has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 9 with negative movement. Key topics include earnings, acquisition. View all AGE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AGE Company Profile & Sector Positioning
AGE (AGE) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NYSE.